RameenBeroukhimMD

Hematologic Oncology, Neuro-Oncology

Assistant Professor of Medicine, Dana-Farber Cancer Institute

Dr. Beroukhim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
University of California San Francisco School of MedicineClass of 2000

PubMed

A sequence context-based approach for classifying tumor structural variants without paired normal samples.
Wolu Chukwu, Siyun Lee, Alexander Crane, Shu Zhang, Sophie Webster
Cell Reports Methods. 2025-03-24
Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification.
Jeremiah Wala, Simona Dalin, Sophie Webster, Ofer Shapira, John Busanovich
Cell Genomics. 2025-03-14
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.
Lisa Mayr, Sina Neyazi, Kallen Schwark, Maria Trissal, Alexander Beck
Cancer Cell. 2025-03-13

Journal Articles

PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma
Rameen Beroukhim, William J Gibson, Clinical Cancer Research
Author Correction: Targeting Wild-Type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 Inhibition
Daniel Catenacci, Adam J Bass, Shaunt Fereshetian, Rameen Beroukhim, Nature
Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug Response
Todd R Golub, Rameen Beroukhim, Pratiti Bandopadhayay, Nature
Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes
Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature
SvABA: Genome-Wide Detection of Structural Variants and Indels by Local Assembly
Marcin Imielinski, Pratiti Bandopadhayay, Jeremiah A Wala, Rameen Beroukhim, Genes & Development
Join now to see all

EMBARGOED: Study Reveals Activity of Navtemadlin in Glioblastoma, Points to Possible Treatment ImprovementsFebruary 19th, 2025
Everything ChangesMay 27th, 2020
Study Eyes Partially Lost Essential Genes as Possible Targets in CancerMay 25th, 2020
Join now to see all

Synthetic lethalities to cell cycle disruption in gliomaDANA-FARBER CANCER INST2022–2027
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing DataBROAD INSTITUTE, INC.2021–2026
Evolution of gliomas during treatment and resistanceDANA-FARBER CANCER INST2015–2026
Evolution of gliomas during treatment and resistanceDANA-FARBER CANCER INST2015–2026